Skip to main content

Table 2 Multivariate competing risk model for LC-SM in patients with lung ASC

From: A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma

Characteristics Coefficient SHR (95% CI) P
Age 0.008   0.15
Age’ 0.003   0.62
Sex
 Female Reference Reference  
 Male 0.228 1.26 (1.13–1.40) < 0.001
Surgery
 No    
 Yes −0.798 0.45 (0.39–0.52) < 0.001
T stage
 T1 Reference Reference  
 T2 0.416 1.52 (1.30–1.77) < 0.001
 T3 0.817 2.26 (1.82–2.81) < 0.001
 T4 0.783 2.19 (1.82–2.63) < 0.001
N stage
 N0 Reference Reference  
 N1 0.398 1.49 (1.26–1.76) < 0.001
 N2 0.5 1.65 (1.43–1.90) < 0.001
 N3 0.469 1.60 (1.28–2.00) < 0.001
M stage
 M0 Reference Reference  
 M1 0.477 1.61 (1.40–1.86) < 0.001
  1. Abbreviations: ASC adenosquamous carcinoma, CI confidence interval, LC-SM lung cancer-specific mortality, SHR subdistribution hazard ratio